Literature DB >> 21552855

Mutations of ras genes in human tumors (review).

H Kiaris1, D Spandidos.   

Abstract

Ras family genes (H-, K- and N-ras) are implicated in a wide range of human rumours. Mutations are a major activating mechanism for the ras family genes, mainly in codons 12, 13 and 61, resulting in their conversion from proto-oncogenes to activated oncogenes. The detection of mutant ras alleles in human tumours has been performed by several investigators in a wide range of tissues. The aim of our review was to summarize the data obtained from these studies and to investigate whether the presence of mutant ras alleles was associated with particular clinical parameters.

Entities:  

Year:  1995        PMID: 21552855

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  30 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Altered glucose metabolism in Harvey-ras transformed MCF10A cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

3.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.

Authors:  D N Dokianakis; M N Varras; M Papaefthimiou; J Apostolopoulou; H Simiakaki; E Diakomanolis; D A Spandidos
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

6.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

7.  1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; Jin Shi; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-22       Impact factor: 4.292

Review 8.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 9.  Allosteric activation transitions in enzymes and biomolecular motors: insights from atomistic and coarse-grained simulations.

Authors:  Michael D Daily; Haibo Yu; George N Phillips; Qiang Cui
Journal:  Top Curr Chem       Date:  2013

10.  Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.

Authors:  Y-H Park; S-U Kim; T-H Kwon; J-M Kim; I-S Song; H-J Shin; B-K Lee; D-H Bang; S-J Lee; D-S Lee; K-T Chang; B-Y Kim; D-Y Yu
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.